Skip to main content
All lobbying filings

ABBOTT LABORATORIES

Lobbying for ABBOTT LABORATORIES

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $1,128,989.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 7
  • HR 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
  • S 2477
    Equitable Community Access to Pharmacist Services Act
  • HR 1770
    Equitable Community Access to Pharmacist Services Act
  • S 2922
    Advancing Research for Chronic Pain Act of 2023
  • HR 7164
    Advancing Research for Chronic Pain Act of 2024
  • S 1000
    Saving Access to Laboratory Services Act
  • HR 1835
    Saving Access to Laboratory Services Act
 Lobbying activity 7
Tariff (miscellaneous tariff bills)

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.

Law Enforcement/Crime/Criminal Justice

Proposals related to third party litigation reform.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Health Issues

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Medicare/Medicaid

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem